CELL — Cellularline SpA Cashflow Statement
0.000.00%
- €54.10m
- €67.90m
- €164.26m
- 71
- 94
- 78
- 97
Annual cashflow statement for Cellularline SpA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 13.9 | -3.85 | -75.2 | 3.6 | 5.65 |
Depreciation | |||||
Non-Cash Items | -16.9 | -0.649 | 0.94 | 0.564 | 2.39 |
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -0.578 | 4.58 | -8.96 | -4.52 | -0.229 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Net Change in Other Assets & Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 11.3 | 19.1 | 4.89 | 13 | 21.5 |
Capital Expenditures | -10.2 | -5 | -4.61 | -4.89 | -5.31 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | -13.8 | -2.37 | -0.786 | -2.55 | — |
Acquisition of Business | |||||
Cash from Investing Activities | -24 | -7.36 | -5.39 | -7.45 | -5.31 |
Financing Cash Flow Items | 6.86 | -3.3 | -1.32 | -0.837 | -4.95 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -10.8 | -12.9 | 1.48 | -2.56 | -9.66 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -23.5 | -0.491 | 1.78 | 4.13 | 6.71 |